Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

NBY – novabay pharmaceuticals, inc. (US:AMEX)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NBY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/28
06:04 am
nby
Form EFFECT NovaBay Pharmaceuticals,
Medium Report
Form EFFECT NovaBay Pharmaceuticals,
Report
11/25
05:27 pm
nby
Form S-8 NovaBay Pharmaceuticals,
High Report
Form S-8 NovaBay Pharmaceuticals,
Report
11/25
05:25 pm
nby
Form S-3/A NovaBay Pharmaceuticals,
High Report
Form S-3/A NovaBay Pharmaceuticals,
Report
11/7
04:02 pm
nby
Form 10-Q NovaBay Pharmaceuticals, For: Sep 30
Low Report
Form 10-Q NovaBay Pharmaceuticals, For: Sep 30
Report
11/3
09:39 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
Low Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
Report
11/3
09:39 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: R01 Capital LLC
Low Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: R01 Capital LLC
Report
11/3
09:38 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
Low Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
Report
10/22
09:27 pm
nby
Form 4/A NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
Medium Report
Form 4/A NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
Report
10/22
09:22 pm
nby
Form 3/A NovaBay Pharmaceuticals, For: Oct 09 Filed by: Framework Ventures Management LLC
Medium Report
Form 3/A NovaBay Pharmaceuticals, For: Oct 09 Filed by: Framework Ventures Management LLC
Report
10/22
04:09 pm
nby
Form 8-K NovaBay Pharmaceuticals, For: Oct 16
High Report
Form 8-K NovaBay Pharmaceuticals, For: Oct 16
Report
10/21
07:01 am
nby
Form 8-K NovaBay Pharmaceuticals, For: Oct 20
Low Report
Form 8-K NovaBay Pharmaceuticals, For: Oct 20
Report
10/20
09:42 pm
nby
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Framework Ventures IV L.P.
High Report
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Framework Ventures IV L.P.
Report
10/20
09:42 pm
nby
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: R01 Fund LP
High Report
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: R01 Fund LP
Report
10/20
09:40 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
High Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Framework Ventures Management LLC
Report
10/20
09:40 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
High Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
Report
10/20
09:39 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: R01 Capital LLC
High Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: R01 Capital LLC
Report
10/20
09:38 pm
nby
Form 3 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
High Report
Form 3 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Kazley Michael John
Report
10/20
09:37 pm
nby
Form 3 NovaBay Pharmaceuticals, For: Oct 09 Filed by: Framework Ventures Management LLC
High Report
Form 3 NovaBay Pharmaceuticals, For: Oct 09 Filed by: Framework Ventures Management LLC
Report
10/20
09:37 pm
nby
Form 3 NovaBay Pharmaceuticals, For: Oct 09 Filed by: R01 Capital LLC
High Report
Form 3 NovaBay Pharmaceuticals, For: Oct 09 Filed by: R01 Capital LLC
Report
10/20
08:48 am
nby
Form 8-K NovaBay Pharmaceuticals, For: Oct 16
High Report
Form 8-K NovaBay Pharmaceuticals, For: Oct 16
Report
10/17
05:29 pm
nby
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Lazar David E.
High Report
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Lazar David E.
Report
10/17
05:28 pm
nby
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Lazar David E.
High Report
Form 4 NovaBay Pharmaceuticals, For: Oct 16 Filed by: Lazar David E.
Report
10/17
05:11 pm
nby
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: POPLAR POINT CAPITAL MANAGEMENT LLC
High Report
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: POPLAR POINT CAPITAL MANAGEMENT LLC
Report
10/15
08:29 pm
nby
Form SCHEDULE 13D NovaBay Pharmaceuticals, Filed by: Framework Ventures IV L.P.
High Report
Form SCHEDULE 13D NovaBay Pharmaceuticals, Filed by: Framework Ventures IV L.P.
Report
10/15
08:29 pm
nby
Form SCHEDULE 13D NovaBay Pharmaceuticals, Filed by: R01 Fund LP
High Report
Form SCHEDULE 13D NovaBay Pharmaceuticals, Filed by: R01 Fund LP
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0